Keynote speakers at the cell signaling meeting in Luxembourg have provided chapters on hypoxia signal transduction, phosphoserine/threonine-binding domains, targeting of polycomb repressive complexes, conserved signaling mechanisms in innate immunity, and signal transduction by stress-activated MAP kinases. Other topics included among these reports on recent research are receptor signaling, protein kinase cascades as therapeutic targets, cell death in cancer, inflammation-specific signaling, cell signaling pathways leading to regulated chromatin modifications, and transcriptional control.
The chapters have been published in four volumes (Part A to D), offering a comprehensive overview about this exciting topic.
This second volume focuses on basic research, and the chapters are divided into the following sections: oxidative stress, transcriptional control, HDAC, and novel technological and therapeutic approaches.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Marc Diederich is the editor of Signal Transduction Pathways, Part B: Stress Signaling and Transcriptional Control, Volume 1091, published by Wiley.
This is the second volume to emerge from the cell signaling meeting in Luxembourg (see Part A) to discuss therapeutic applications in the field of signal transduction, transcription, and translation. These meetings and the volumes comprising their proceedings have brought forward new insights in this rapidly moving field. These volumes focus on the therapeutic potential for targeting cell signaling mechanisms with particular attention to cancer therapies and inflammatory signaling pathways as well as immunomodulation.
Part B focuses on basic research, and the chapters are divided into the following sections: oxidative stress, transcriptional control, HDAC, and novel technological and therapeutic approaches.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit www.nyas.org/membership/main.asp for more information about becoming a member.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Da: Research Ink, Takoma Park, MD, U.S.A.
Paperback. Condizione: Very good. xxvii + 573 pp. Annals of the New York Academy of Sciences, volume1091. Rubber-stamped on half title page. book. Codice articolo 32341
Quantità: 1 disponibili
Da: PsychoBabel & Skoob Books, Didcot, Regno Unito
paperback. Condizione: Very Good. Condizione sovraccoperta: No Dust Jacket. minor bumps to the ends of the cover, Codice articolo 105521
Quantità: 1 disponibili
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Codice articolo ABEOCT25-172408
Quantità: 1 disponibili
Da: Mispah books, Redhill, SURRE, Regno Unito
Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book. Codice articolo ERICA77515733164746
Quantità: 1 disponibili